- View programme as: Grid view List view
- Print: Print
- Search
- Personal Planner
Sun 18 March
- 06:00
- 07:00
- 08:00
- 09:00
- 10:00
- 11:00
- 12:00
- 13:00
- 14:00
- 15:00
- 16:00
- 17:00
- 18:00
- 19:00
- 20:00
- 21:00
-
Green Area, eURO Auditorium (Level 0)
-
- 06:00
- 07:00
- 08:00
- 09:00
- 10:00
- 11:00
- 12:00
- 13:00
- 14:00
- 15:00
- 16:00
- 17:00
- 18:00
- 19:00
- 20:00
- 21:00
-
Green Area, eURO Auditorium (Level 0)
-
Plenary Session 3 - Prostate cancer
Prostate cancer Plenary Session 3
Prostate cancer
Plenary Session 3
-
Location:Green Area, eURO Auditorium (Level 0)
-
Chairs:
-
Aims and objectives of this session This initial part of the session aims to illustrate the level and availability of genomic information needed to risk classify profile tumours according to their genetic profile. The audience will understand why efforts are made to develop genetic tests, and what is needed to make this a clinical tool.
Debate Genomic screening before active surveillance - Enough data? Discussion
Case-based debate Positron Emission Tomography–Computed Tomography (PET-CT) detected oligometastatic disease Discussion
Case-based debate Locally advanced non-metastatic cancer in elderly patients Discussion
-
-
- 06:00
- 07:00
- 08:00
- 09:00
- 10:00
- 11:00
- 12:00
- 13:00
- 14:00
- 15:00
- 16:00
- 17:00
- 18:00
- 19:00
- 20:00
- 21:00
-
Green Area, eURO Auditorium (Level 0)
-
Green Area, Room 1 (Level 0)
-
Green Area, Room 2 (Level 0)
-
Red Area, Room 1 (Level 0)
-
Red Area, Room 2 (Level 0)
-
Red Area, Room 3 (Level 0)
-
Blue Area, Room 1 (Level 0)
-
Blue Area, Room 2 (Level 0)
-
Blue Area, Room 3 (Level 0)
-
Blue Area, Room 4 (Level 0)
-
Blue Area, Room 5 (Level 0)
-
Green Area, Room 15 (Level 0)
-
Green Area
-
Green Area, Room 10 (Level 1)
-
Green Area, Room 12 (Level 1)
-
Green Area, Room 11 (Level 1)
-
Orange Area, Room 1 (Level 0)
-
Orange Area, Room 2 (Level 0)
-
Orange Area, Room 3 (Level 0)
-
Orange Area, Room 4 (Level 0)
-
Orange Area, Room 5 (Level 0)
-
Orange Area, Room 6 (Level 0)
-
Orange Area, Room 7 (Level 0)
-
Yellow Area, Room 1 (Level 0)
-
Yellow Area, Room 2 (Level 0)
-
Yellow Area, Room 3 (Level 0)
-
Yellow Area, Room 4 (Level 0)
-
Yellow Area, Room 5 (Level 0)
-
Yellow Area, Iglo
-
- 06:00
- 07:00
- 08:00
- 09:00
- 10:00
- 11:00
- 12:00
- 13:00
- 14:00
- 15:00
- 16:00
- 17:00
- 18:00
- 19:00
- 20:00
- 21:00
-
Green Area, eURO Auditorium (Level 0)
-
Consensus Highlight - EAU Consensus highlight and game changing session
EAU Consensus highlight and game changing session Consensus Highlight
-
Plenary session - Game changing session
Game changing session Plenary session
Game changing session
Plenary session
-
Plenary Session 3 - Prostate cancer
Prostate cancer Plenary Session 3
Prostate cancer
Plenary Session 3
-
Location:Green Area, eURO Auditorium (Level 0)
-
Chairs:
-
Aims and objectives of this session This initial part of the session aims to illustrate the level and availability of genomic information needed to risk classify profile tumours according to their genetic profile. The audience will understand why efforts are made to develop genetic tests, and what is needed to make this a clinical tool.
Debate Genomic screening before active surveillance - Enough data? Discussion
Case-based debate Positron Emission Tomography–Computed Tomography (PET-CT) detected oligometastatic disease Discussion
Case-based debate Locally advanced non-metastatic cancer in elderly patients Discussion
-
-
Plenary Session 5 - Precision medicine
Precision medicine Plenary Session 5
Precision medicine
Plenary Session 5
Case-based debate Is Prostate-Specific Membrane Antigen (PSMA)-Positron Emission Tomography–Computed Tomography (PET-CT) for Prostate-Specific Antigen (PSA) relapse worth the trouble? Discussion
Case-based debate BRCA1/2 testing before treatment of metastatic Castration-Resistant Prostate Cancer (mCRPC) Discussion
-
Plenary Session 7 - Stones
Stones Plenary Session 7
Stones
Plenary Session 7
-
Location:Green Area, eURO Auditorium (Level 0)
-
Chairs:
-
Aims and objectives of this session Stones belong to the most common diseases, comparable with diabetes or hypertension. Management of urolithiasis is therefore daily business of most urologist. This plenary will cover important aspects and developments in pathogenesis, diagnosis, interventional treatment and prevention of urinary stones.
Case-based debate How can we evaluate and treat the high-risk stone former? Discussion
Debate Single-use flexible Ureteroscopy (URS): Ready to become standard? Discussion
Case-based panel discussion Nightmares in ureteroscopy and percutaneous nephrolithotomy Debate Did patients benefit from miniaturisation of Percutaneous Nephrolithotomy (PNL)? Discussion
Souvenir Sessions By the EAU Scientific Committee -
-
Plenary Session 1 - Hot topics, evidence quality and advances in andrology
Hot topics, evidence quality and advances in andrology Plenary Session 1
Hot topics, evidence quality and advances in andrology
Plenary Session 1
-
Location:Green Area, eURO Auditorium (Level 0)
-
Chairs:
-
Aims and objectives of this session In recent years, deteriorating semen quality has been increasingly observed. Various researchers have identified changing lifestyle choices, such as delayed fatherhood and increased anabolic steroid abuse, but also increased exposure to environmental gonadotoxins as potential important causes of this phenomenon. In this plenary, an overview of these issues will be given, and the urologist will be updated on surgical options for the management of male infertility problems.
In the second half of the session, the focus will be on emerging therapies in andrology which are claimed to possess potential curative capacities such as low intensity shockwaves and cellular therapies. The quality of evidence supporting these novel therapies will be discussed in a case-based fashion.
Case-based debate Low intensity Extracorporeal Shockwave Therapy (ESWT) for Erectile Dysfuntion (ED) Discussion
-
-
Meeting of the EAU Section of Uro-Technology (ESUT) in cooperation with the EAU Robotic Urology Section (ERUS) and the EAU Section of Urolithiasis (EULIS) - Technology Strikes Back
Technology Strikes Back Meeting of the EAU Section of Uro-Technology (ESUT) in cooperation with the EAU Robotic Urology Section (ERUS) and the EAU Section of Urolithiasis (EULIS)
Technology Strikes Back
Meeting of the EAU Section of Uro-Technology (ESUT) in cooperation with the EAU Robotic Urology Section (ERUS) and the EAU Section of Urolithiasis (EULIS)
-
Location:Green Area, eURO Auditorium (Level 0)
-
Chair:
-
Aims and objectives of this session Following a more than 10-year tradition of live-surgery sessions, the EAU Section of Uro-Technology (ESUT) presents an ambitious programme focussing on novel techniques and technologies in endourological, laparoscopic and robotic-assisted procedures. This year, we want to focus on novel technology improving the performance of video-assisted surgery and diagnostics in all fields of Endourology. This session is conducted in collaboration with the the EAU Robotic Urology Section (ERUS) and the EAU Section of Urolithiasis (EULIS). In the laparoscopic and robot-assisted cases, we will focus on the developments of imaging as well as on new instruments and devices that improve its ergonomics. The latest digital developments for flexible endoscopy of the upper urinary tract for diagnosis and treatment of tumours and calculi will also be demonstrated.
ESUT faculty consists of internationally well-known experts serving as surgeons and moderators. The different surgical procedures will be transmitted from Herlev Hospital in Copenhagen in high definition and 3D quality. Traditionally, the format of ESUT Live Surgery will allow all delegates to directly communicate with the surgeons to ask questions and to discuss every aspect of the procedure. In addition, the ESUT session will also be available online.
Live broadcasts from Herlev Hospital, Copenhagen (DK) Coordinators in the eURO Auditorium Coordinator at Herlev Hospital, Copenhagen (DK) Patient Advocates Live Surgery Part I Live Surgery Part II Live Surgery Part III Live Surgery Part IV -
-
Specialty Session - Latest and hot news in medical treatment in onco-urology
Latest and hot news in medical treatment in onco-urology Specialty Session
Latest and hot news in medical treatment in onco-urology
Specialty Session
Conclusions from recent oncology meetings regarding: -
Video Session 09 - Technological solutions for BPH
Technological solutions for BPH Video Session 09
Technological solutions for BPH
Video Session 09
V64Laser enucleation techniques in residual BPH management
By: Enikeev D. , Glybochko P. , Alyaev Y. , Rapoport L. , Enikeev M. , Sorokin N. , Sukhanov R. , Taratkin M.
Institutes: I.M. Sechenov First Moscow State Medcal University, Research Institute of Uronephrology and Reproductive Health, Moscow, Russia
V65Thulium fiber laser enucleation of the prostate in management of giant BPH (>200 cc)
By: Enikeev D. , Glybochko P. , Alyaev Y. , Rapoport L. , Enikeev M. , Taratkin M.
Institutes: I.M. Sechenov First Moscow State Medical University, Research Institute For Uronephrology And Reproductive Health, Moscow, Russia
V66Robot-assisted “pure” adenomectomy for large prostate adenoma: Is it the way to solve the bladder outlet obstruction and maintain a normal sexual function?
By: Porpiglia F. , Fiori C. , Bertolo R. , Checcucci E. , Amparore D. , Scarpa R.M.
Institutes: AOU San Luigi Gonzaga Orbassano – Turin; University of Turin, Dept. of Urology, Orbassano, Italy
V67Recommendations for safe and efficient morcellation after endoscopic enucleation of the prostate (EEP)
By: Rijo E. 1 , Misrai V. 2 , Gomez-Sancha F. 3
Institutes: 1Hospital Quiron Barcelona, Dept. of Urology, Barcelona, Spain, 2Clinique Pasteur, Dept. of Urology, Toulouse, France, 3ICUA-Clínica CEMTRO, Dept. of Urology, Madrid, Spain
V68V69V63Transvesical robotic simple prostatectomy with 360° circumferential reconstruction: Step-by-step technique
By: Cacciamani G.E. 1 , Medina L. 1 , Ashrafi A.N 1 , Landsberger H. 1 , Winter M. 1 , Desai M. 1 , Aron M. 1 , Berger A. 2
Institutes: 1University of Southern California, Dept. of Urology, Los Angeles, United States of America, 2USC Institute of Urology, Dept. of Urology, Los Angeles, United States of America
-
Video Session 06 - Bladder cancer: Minimally invasive approaches
Bladder cancer: Minimally invasive approaches Video Session 06
Bladder cancer: Minimally invasive approaches
Video Session 06
V41Robot-assisted laparoscopic en-bloc partial cystectomy, urachal resection, umbilectomy and pelvic lymphadenectomy with intracorporeal ultrasonography for urachal adenocarcinoma: A case report
By: Proskura A. , Shpot E.
Institutes: Sechenov University, Dept. of Urology, Moscow, Russia
V42V44V45Palliative cystectomy: Presentation of 3 cases
By: Medina Gonzalez A. , Perez Garcia C. , Gonzalez Rodriguez I. , Diaz Mendez B. , Cruceyra Betriu G. , Gil Ugarteburu R. , Fernandez-Pello Montes S. , Rúger Jiménez L. , Mosquera Madera J.
Institutes: Hospital of Cabueñes, Dept. of UROLOGY, Gijón, Spain
V46Endoscopic incision for uretero-ileal anastomotic stricture: Step by step technique
By: Pérez Schoch M. 1 , Carballo Quintá M. 1 , Almuster Domínguez S. 1 , Castro Iglesias M. 1 , Sánchez Ramos J. 1 , Montero Fabuena R. 1 , Díaz Álvarez J.M. 1 , Martínez Vázquez A. 2 , López García S. 1 , López Díez M.E. 1 , Martínez-Sapiña Llanas I. 1 , Barros Rodríguez J.M. 1 , Ojea Calvo A. 1
Institutes: 1Hospital Álvaro Cunqueiro, Dept of Urology, Vigo, Spain, 2Hospital Álvaro Cunqueiro, Dept. of Radiology, Vigo, Spain
V47V40Robot assisted totally intracorporeal Vescica Ileale Padovana (ra-VIP): A new technique for robotic bladder replacement
By: Cacciamani G.E. , De Marco V. , Sebben M. , Rizzetto R. , Cerruto M.A. , Porcaro A.B. , Artibani W.
Institutes: AOUI, Azienda Ospedaliera Universitaria Integrata, Dept. of Urology, Verona, Italy
-
Video Session 07 - Developments in endourology
Developments in endourology Video Session 07
Developments in endourology
Video Session 07
V48Feasibility of a single use disposable diagnostic digital cystoscope: Initial clinical experience
By: Ostrowski A. 1 , Kowalski F. 2 , Banas M. 1 , Goli V. 3 , Denes B. 4 , Drewa T. 1
Institutes: 1Nicolaus Copernicus University, Dept. of Oncological Urology, Bydgoszcz, Poland, 2Nicolaus Copernicus University, Dept of Oncological Urology, Bydgoszcz, Poland, 3Las Vegas Urology, Dept. of Urology, Las Vegas, United States of America, 4UroViu, Dept. of Clinical Development, Redwood City, United States of America
V49Green Light Laser for management of haemorrhergic cystitis – technique and initial results
By: Pascoe C. 1 , Christidis D. 2 , Manning T. 2 , Lamb B. 3 , Murphy D. 1 , Lawrentschuk N. 1
Institutes: 1Peter MacCallum Cancer Center, Dept. of Cancer Surgery, Melbourne, Australia, 2Austin Health, Dept. of Surgery , Melbourne, Australia, 3Peter MacCallum Cancer Centre, Dept. of Cancer Surgery, Melbourne, Australia
V50V51’’PiReS’’: How to build a bladder model for Pigtail Removal Simulation
By: Liakos N. , Henke C.A. , Franco P. , Wagner C. , Witt J.H.
Institutes: St. Antonius Hospital Gronau, Dept. of Urology, Pediatric Urology and Urological Oncology, Prostate Center Northwest, Gronau, Germany
V52Surgical anatomy and changes in the morphology of the external urethral sphincter after endoscopic enucleation of the prostate measured by transrectal ultrasound
By: Rijo E. 1 , Gil-Vernet J.M. 2
Institutes: 1Hospital Quiron Barcelona, Dept. of Urology, Barcelona, Spain, 2Clínica Teknon Barcelona, Dept. of Urology, Barcelona, Spain
V53V54“En bloc” thullium laser resection of NMIBC: Technique and preliminary results
By: Hurle R. , Saita A. , Lazzeri M. , Buffi N. , Lughezzani G. , Peschechera R. , Benetti A. , Pasini L. , Zandegiacomo S. , Lista G. , Cardone P. , Guazzoni G. , Casale P.
Institutes: Istituto Clinico Humanitas IRCCS, Dept. of Urology, Rozzano, Italy
V55PDD-guided thulium fiber laser en-bloc enucleation of bladder tumor
By: Glybochko P. , Alyaev Y. , Rapoport L. , Enikeev D. , Enikeev M. , Sorokin N. , Sukhanov R. , Dymov A. , Taratkin M.
Institutes: I.M. Sechenov First Moscow State Medcal University, Research Institute of Uronephrology and Reproductive Health, Moscow, Russia
-
Video Session 10 - Innovative techniques for improving lymph node management
Innovative techniques for improving lymph node management Video Session 10
Innovative techniques for improving lymph node management
Video Session 10
V70Anatomical 3D image guidance for real-time lymph node localization during robot-assisted salvage lymphadenectomy
By: Önol F.F. , Palayapalayam Ganapathi H. , Rogers T. , Roof S. , Patel V.
Institutes: Florida Hospital Global Robotics Institute, Dept. of Urology, Celebration, United States of America
V71Laparoscopic inguinal and pelvic lymphadenectomy in the penile cancer. A novel abdominal approach
By: Martinez Holguin E. , Subira Rios D. , Andres Boville G. , Jara Rascon J. , Moralejo Garate M. , Rodriguez Fernandez E. , Bueno Chomon G. , Hernandez Fernandez C.
Institutes: Hospital General Universitario Gregorio Marañón, Dept. of Urology, Madrid, Spain
V72Left post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND): Stage IIB seminoma
By: Baldissera Aradas J.V. , Miranda Aranzubia O. , Pérez Cadavid S. , Casas Agudo V. , Orosa Andrada A. , López León V. , Rivas Escudero J. , López Rellán E.
Institutes: Bierzo hospital, Dept. of Urology, Ponferrada, Spain
V73V74Surgical feasibility, and outcome of robot-assisted video endoscopic inguinal lymph node dissection in node positive groin of carcinoma penis patients
By: Singh A. , Jaipuria J. , Baidya S. , Kumar R. , Jain J. , Rawal S.
Institutes: Rajiv Gandhi Cancer Institute and Research Centre, Dept of Uro-Oncology, Delhi, India
V75Robot-assisted salvage lymph node dissection for nodal recurrence of prostate cancer
By: Brassetti A. , Proietti F. , Del Vecchio G. , Emiliozzi P. , Martini M. , Pansadoro A. , Scarpone P. , Pansadoro V.
Institutes: Vincenzo Pansadoro Foundation, Dept. of Urology, Rome, Italy
V76Salvage robot-assisted retroperitoneal lymphadenectomy for prostate cancer nodal recurrence only detected by 68Ga-PSMA PET CT: Technical aspects and results
By: Mota Filho F.H.A. , Savio L.F. , Santos R. , Da Cruz J.A.S. , Passerotti C.C.
Institutes: Hospital Alemão Oswaldo Cruz, Centro de Cirurgia Robótica, São Paulo, Brazil
-
Video Session 08 - Emerging techniques in robotic renal surgery
Emerging techniques in robotic renal surgery Video Session 08
Emerging techniques in robotic renal surgery
Video Session 08
V56V57Robot-assisted nephrectomy and IVC thrombectomy in the treatment of renal cell carcinoma
By: Juárez Del Dago Anaya P. 1 , Gaston R. 2 , Cuadros Rivera V. 2 , Llanes González L. 2 , Reinoso J. 2 , Fernández Del Álamo J. 2 , Gomez Sancha F. 2
Institutes: 1Gabinete de Urologia y Andrología, Dept. of Urology, Las Palmas de Gran Canaria, Spain, 2ICUA - Clinica CEMTRO, Dept. of Urology, Madrid, Spain
V58ICG marked off-clamp robotic partial nephrectomy for endophytic renal tumors: Proof of concept and initial series
By: Simone G. 1 , Misuraca L. 1 , Tuderti G. 1 , Ferriero M. 1 , Minisola F. 1 , Vallati G. 2 , Pizzi G. 2 , Guaglianone S. 1 , Gallucci M. 1
Institutes: 1Regina Elena National Cancer Institute, Dept. of Urology, Rome, Italy, 2Regina Elena National Cancer Institute, Dept. of Radiology, Rome, Italy
V59Robot-assisted partial nephrectomy with enucleative resection strategy for highly complex renal masses: Results from a high-volume referral cancer centre
By: Minervini A. , Campi R. , Mari A. , Sessa F. , Vanacore D. , Sforza S. , Tasso G. , Di Maida F. , Bencini G. , Morselli S. , Lapini A. , Carini M.
Institutes: University of Florence, Dept. of Urology, Florence, Italy
V60V61V623D-modeling for vascular anatomy reconstruction before robotic partial nephrectomy
By: Schiavina R. 1 , Angiolini A. 1 , Borghesi M. 1 , Bianchi L. 1 , Chessa F. 1 , Vagnoni V. 1 , Mineo Bianchi F. 1 , Barbaresi U. 1 , Marcelli E. 2 , Bortolani B. 2 , Cercenelli L. 2 , Brunocilla E. 1
Institutes: 1Sant'Orsola-Malpighi Hospital - University of Bologna, Dept. of Urology, Bologna, Italy, 2University of Bologna, Dept. of Bioengineering, Bologna, Italy
-
Video Session 11 - Complex reconstructive genital surgery
Complex reconstructive genital surgery Video Session 11
Complex reconstructive genital surgery
Video Session 11
V77Gender confirmation vaginoplasty: The Chicago technique
By: Kocjancic E. 1 , Vigneswaran H. 1 , Sofer L. 1 , Jaunarena J. 1 , Whitehead D. 2 , Morgantini L.A. 1 , Schechter L. 2
Institutes: 1University of Illinois at Chicago, Dept. of Urology, Chicago, United States of America, 2Weiss Memorial Hospital, Dept. of Plastic Surgery, Chicago, United States of America
V78A multi-center analysis on surgical technique, outcomes and learning curve of male-to-female penoscrotal vaginoplasty
By: Cocci A. 1 , Polloni G. 2 , Delle Rose A. 1 , Grisanti Caroassai S. 1 , Cito G. 1 , Serni S. 1 , Carini M. 1 , Matteucci V. 3 , Morelli G. 4
Institutes: 1University of Florence, Dept. of urology, Florence, Italy, 2Psycho-Sexology, Dept. of Psycho-Sexology, Milan, Italy, 3Cisanello Hospital, Dept. of Surgery, Pisa, Italy, 4Cisanello Hospital, Dept. of urology, Pisa, Italy
V79Bladder exstrophy radial artery phalloplasty: Exstrophy related issues and saphenous vein interposition graft
By: Chiriacò G. , Blecher G. , Johnson M. , Sangster P. , Christopher N. , Ralph D.
Institutes: University College London Hospitals (UCLH), Dept. of Andrology, London, United Kingdom
V80Surgical technique for complex cases of Peyronie’s disease: Penile prosthesis implantation, modified neurovascular bundle release and single or multiple corporeal incisions and grafting with collagen fleece
By: Fernández-Pascual E. 1 , González-García J. 2 , Souto A.D. 1 , García E. 1 , Marcos D. 1 , Turo J. 1 , Carballido J. 1 , Martínez Salamanca J.I. 1
Institutes: 1Puerta de Hierro Majadahonda University Hospital, Dept. of Urology, Madrid, Spain, 2Hospital Central de la Cruz Roja San José y Santa Adela, Dept. of Urology, Madrid, Spain
V81Microsurgical vs robot-assisted vasovasostomy: Technical aspects and results
By: Umari P. 1 , De Naeyer G. 2 , Schatteman P. 2 , De Groote R. 2 , Fossati N. 3 , Gandaglia G. 3 , Heinze A. 2 , Rizzo M. 4 , Pavan N. 4 , Liguori G. 5 , Bucci S. 4 , Mottrie A. 2 , Trombetta C. 4
Institutes: 1Ospedale Maggiore della Carità, Dept. of Urology, Novara, Italy, 2OLV Hospital Aalst, Dept. of Urology, Aalst, Belgium, 3Ospedale San Raffaele, Dept. of Urology, Milan, Italy, 4Cattinara Hospital, Dept. of Urology, Trieste, Italy, 5Cattinara Hospital , Dept. of Urology, Trieste, Italy
V82New transscrotal approach for robotic microsurgical denervation of the spermatic cord with robotic microsurgical varicocelectomy
By: Gudeloglu A. 1 , Etafy M. 2 , Brahmbhatt J. 2 , Parekattil S. 3
Institutes: 1Hacettepe University Medical Faculty, Dept. of Urology, Ankara, Turkey, 2PUR Clinic , Dept. of Urology, Clermont, United States of America, 3PUR Clinic, Dept. of Urology, Clermont, United States of America
V83Penile sclerosing granuloma - surgical excision
By: Blecher G. 1 , Asher N. 2 , Chiriacò G. 1 , Ralph D.J. 1
Institutes: 1University College of London Hospital, Dept. of Andrology, London, United Kingdom, 2University College of London Hospital, Dept. of Pathology, London, United Kingdom
V84Surgical management of severe post-operative skin necrosis after penile lengthening corporoplasty
By: Colombo F. , Gentile G. , Franceschelli A. , Vagnoni V. , Angiolini A. , Sadini P.
Institutes: Andrology Unit - S. Orsola University Hospital, Dept. of Urology and Gynecology, Bologna, Italy
-
Opening Ceremony - EAU Opening Ceremony
EAU Opening Ceremony Opening Ceremony
EAU Opening Ceremony
Opening Ceremony
-
Location:Green Area, eURO Auditorium (Level 0)
Welcome by Commissioner Andriukaitis
Announcement of the new EAU Honorary Members
Presentation of the EAU Willy Gregoir Medal 2018
Presentation of the EAU Frans Debruyne Life Time Achievement Award 2018
Presentation of the EAU Crystal Matula Award 2018
Presentation of the EAU Hans Marberger Award 2018
EAU Ernest Desnos Prize
Presentation of the EAU Prostate Cancer Research Award 2018
-
-
-
Green Area, Room 1 (Level 0)
-
Plenary Session 4 - Contemporary storage Lower Urinary Tract Symptoms (LUTS) management
Contemporary storage Lower Urinary Tract Symptoms (LUTS) management Plenary Session 4
Contemporary storage Lower Urinary Tract Symptoms (LUTS) management
Plenary Session 4
-
Location:Green Area, Room 1 (Level 0)
-
Chairs:
-
Aims and objectives of this session The aims and objectives of this session are to emphasise the fact that overactive bladder is a non-specific symptom complex and indeed "the bladder is an unreliable witness" and that there are a number of potential physiological causes for the symptom complex overactive bladder. Treatment options after failed conservative management and drug therapy will be discussed.
Continuing the theme of this session, lower urinary tract symptoms in the context of both stable and progressive neurogenic disease states and the important issue of age and the influence of polypharmacy when considering the management of OAB will be addressed.
A case presentation will focus on the dilemma concerning lower urinary tract symptoms associated with benign prostatic obstruction and the effect of surgery to relieve obstruction on these symptoms.
Take home message: The attendee at this session will understand the non-specific nature of urinary tract symptoms and appreciate current concepts on the appropriate investigation and management thereof including the potential effect of surgery for benign prostatic obstruction on associated lower urinary tract symptoms.
-
-
Plenary Session 6 - Preventing urological disease: Future prospects
Preventing urological disease: Future prospects Plenary Session 6
Preventing urological disease: Future prospects
Plenary Session 6
-
Location:Green Area, Room 1 (Level 0)
-
Chairs:
-
Aims and objectives of this session Disease prevention is a topic of increasing importance throughout the medical field. Here the focus is on preventing urological diseases by addressing systemic disease processes: Preventing or slowing the progression of lower urinary tract symptoms, minimising invasive urological procedures in high-risk patients with multiple co-morbidities, and mitigating urological complications associated with other medical conditions. Practical specific care suggestions and solutions for improving lower urinary tract function in patients with other chronic medical conditions will be discussed.
Case-based debate Preventing LUTS by preventing/treating these diseases Late breaking news -
-
Plenary Session 2 - Nightmare session: Bladder cancer management
Nightmare session: Bladder cancer management Plenary Session 2
Nightmare session: Bladder cancer management
Plenary Session 2
-
Location:Green Area, Room 1 (Level 0)
-
Chairs:
-
Aims and objectives of this session The European Association of Urology (EAU) Non-Muscle and/or Muscle Invasive Bladder Cancer (NMIBC) guidelines are meant to help minimise morbidity and improve the care of patients with Bladder Cancer (BC). However, there may be underuse of guideline-recommended care in this potentially curable cohort. One reason is that non-indexed patients are treated by urologists. The incidence of postoperative complications is still the most frequently used surrogate marker of quality in surgery. The EAU guidelines has advocated the use of Clavien-Dindo classification as a standardised approach to grade and report postoperative complications in urology. However, it does not apply for intraoperative complications, and there is a need for an additional tool. In the current session we will discuss three distinct difficult clinical situations coming from the daily practice of urology in BC care. We will discuss issues around these very challenging cases and propose actions to overcome these so-called "nightmare" cases for urologists.
Case-based debate pT0 post cystectomy - "You mean I went through all of this and there was no tumour" Case solution
Case-based debate Complications after a lengthy, complex cystectomy Case solution
Case-based debate Complications following an early re-resection after no muscle in first TURBT Case solution
-
-
Urology beyond Europe - Joint Session of the European Association of Urology (EAU) and the Arab Association of Urology (AAU)
Joint Session of the European Association of Urology (EAU) and the Arab Association of Urology (AAU) Urology beyond Europe
Joint Session of the European Association of Urology (EAU) and the Arab Association of Urology (AAU)
Urology beyond Europe
-
Location:Green Area, Room 1 (Level 0)
-
Chairs:
-
Aims and objectives of this session This session aims to open a channel between European urology and the urologists in the Arab world. The chosen topics include future developments of robotic surgery, urinary stone treatment, andrology and reconstructive urology and European and Arab approaches to solve these problems. Thus all participants will be able to learn from alternatives.
Discussion
Discussion
Discussion
Complications of continent cutaneous urinary diversion and how to avoid To be confirmed
Discussion
-
-
Meeting of the EAU Section of Urolithiasis (EULIS) - Management of stones: Advancing technology, increasing experience and changing concepts. Where are we in 2018?
Management of stones: Advancing technology, increasing experience and changing concepts. Where are we in 2018? Meeting of the EAU Section of Urolithiasis (EULIS)
Management of stones: Advancing technology, increasing experience and changing concepts. Where are we in 2018?
Meeting of the EAU Section of Urolithiasis (EULIS)
-
Location:Green Area, Room 1 (Level 0)
-
Chair:
-
Aims and objectives of this session Technological advancements, coupled with increasing experience have considerably changed our treatment concepts in the contemporary management of stone disease both in adults and children. Currently a very well-planned treatment and follow-up strategy including well-conducted “imaging studies” and “metabolic evaluation” are being considered as the crucial steps for a successful and complication-free outcomes. Moreover, a close follow-up for all cases (if possible on an individual basis particularly in “risk group “ patients) is certainly required to limit future stone recurrences and related complications which may well affect the life quality of stone forming cases. Thus, in this EULIS session, in addition to a close look at the recent developments in minimally invasive stone management particularly in “complex cases”; we will focus on the importance of “experience with tips and tricks” from the experts to increase stone-free rates and limit well known complications. Assessment of stone free status with appropriate timing and tools along with the essentials of follow-up period will be discussed in detail to outline some ongoing debates on these issues.
Metabolic evaluation and medical management of urinary stones Video Session 1: Management of complex renal stones with Percutaneous Nephrolithotomy (PNL) – How I do it? Discussion
Evaluation and follow-up of a stone former Discussion
Complications can occur but how can I lower the risk? Tips and tricks from the experts Discussion
Video Session 2: Management of complex renal stones with Flexible Ureterorenoscopy (FURS) – How I do it? Discussion
What's new in endourology for stones? -
-
Thematic Session 10 - Management of complicated urinary stone disease
Management of complicated urinary stone disease Thematic Session 10
Management of complicated urinary stone disease
Thematic Session 10
-
Location:Green Area, Room 1 (Level 0)
-
Chairs:
-
Aims and objectives of this session Treating stones can be complex due to stone size or location, but as well due to specific comorbidities or anatomic anomalies. Choosing the best approach requires significant expertise and experience of the urologist. This session aims being a very interactive, practical discussion on selected cases to improve personal knowledge on difficult, complex situations.
Case discussion A 2 cm lower pole stone in an obese patient is treated best... Case discussion Pus after puncture of an infectious staghorn stone -
-
Thematic Session 01 - Underactive bladder: Under-diagnosed and under-recognised
Underactive bladder: Under-diagnosed and under-recognised Thematic Session 01
Underactive bladder: Under-diagnosed and under-recognised
Thematic Session 01
-
Location:Green Area, Room 1 (Level 0)
-
Chairs:
-
Aims and objectives of this session The session aims to discuss the pitfalls and advantages of current definitions in terms of research and management of Underactive Bladder (UAB). UAB broadly defines a symptom complex of bladder emptying problems and does not indicate a specific pathology. Pathophysiological mechanisms underlying UAB will be discussed. Treatment of underactive bladder will be reviewed on case studies with pro and con positions: TURP in male with BPO and detrusor hypocontractility, and the case of SNS in a young female with dysfunctional voiding and defecation problems.
-
-
Poster Session 63 - Straight access to the stone: Percutaneous nephrolithotomy
Straight access to the stone: Percutaneous nephrolithotomy Poster Session 63
Straight access to the stone: Percutaneous nephrolithotomy
Poster Session 63
Is PCNL changing in the UK – analysis of 9500 cases from the BAUS PCNL Registry
By: Finch W. 1 , Armitage J. 2 , Withington J. 3 , Irving S. 1 , Fowler S. 4 , Burgess N. 1 , Wiseman O. 2
Institutes: 1Norfolk and Norwich University Hospitals, Dept. of Urology, Norwich, United Kingdom, 2Addenbrookes Hospital, Dept. of Urology, Cambridge, United Kingdom, 3Guy's Hospital, Dept. of Urology, London, United Kingdom, 4BAUS, Audit, London, United Kingdom
856Nephrolithometry scoring systems in percutaneous nephrolithotomy: The Guy’s stone score, S.T.O.N.E. nephrolithometry, CROES nomogram and S-ReSC score
By: Bibi M. , Sellami A. , Ouanes Y. , Chaker K. , Ben Rhouma S. , Nouira Y.
Institutes: Hospital La Rabta, Dept. of Urology, Tunis, Tunisia
857Do culture positive residual fragments have an impact on postoperative SIRS in patients undergoing PNL?
By: Degirmenci T. 1 , Bozkurt I.H. 1 , Çelik S. 1 , Arslan B. 2 , Yonguc T. 1 , Sefik E. 1 , Dincel C. 1
Institutes: 1Bozyaka Education and Research Hospital, Dept. of Urology, Izmir, Turkey, 2Istanbul Taksim Training and Research Hospital, Dept. of Urology, Izmir, Turkey
858Stone culture is not better than bladder urine culture as SIRS predictor after percutaneous nephrolithotomy
By: Corsaro A. , Özsoy M. , Veser J. , Seitz C.
Institutes: Vienna General Hospiral, Dept. of Urology, Vienna, Austria
859860861Assessing irrigation flows influence on clearance of renal calculi fragments during PCNL: A hydrodynamic computerized and practical model study
By: Dekalo S. 1 , Barghouty Y. 1 , Shlain S. 2 , Liberzon A. 3 , Paster A. 3 , Aviram G. 4 , Sofer M. 1
Institutes: 1Tel-Aviv Sourasky Medical Center, Dept. of Urology, Tel-Aviv, Israel, 2School of Mechanical Engineering, Dept. of Hydrology, Tel-Aviv, Israel, 3Tel-Aviv University , Dept. of Hydrology, Tel-Aviv, Israel, 4Tel-Aviv Sourasky Medical Center, Dept. of Radiology, Tel-Aviv, Israel
862The effect of anterior calyx stone on complication and stone free rates in percutaneous nephrolithotomy operations
By: Kalkanli A. 1 , Ozdemir E. 1 , Cilesiz N.C. 1 , Ozkan A. 1 , Arslan B. 1 , Hazar A.I. 1 , Aydin M. 1 , Tandogdu Z. 2
Institutes: 1Taksim Gaziosmanpasa Training and Research Hospital, Dept. of Urology, Istanbul, Turkey, 2Northern Institute for Cancer Research Newcastle University, Dept. of Urology, Newcastle, United Kingdom
V87Associated video presentation Making the access to the upper calyx in supine position safer: ultrasound and miniperc
By: Cepeda Delgado M. 1 , Poza M. 1 , Tapia A.M. 1 , García A. 1 , Miralles S. 2 , Mainez J.A. 1 , Alonso D.M. 1 , Amón J.H. 1
Institutes: 1Río Hortega University Hospital, Dept. of Urology, Valladolid, Spain, 2Rio Hortega University Hospital, Dept. of Urology, Valladoid, Spain
863Massive vs limited pneumatic stone disintegration in PCNL for stag horn stone: A randomized study
By: Gamal Saad W. , Mmdouh A.
Institutes: Sohag University Hospital, Dept. of Urology, Sohag, Egypt
864Mini-PCNL versus standard-PCNL for the management of 20-40 mm size kidney stones: The initial result of a multi-center randomized controlled trial
By: Zeng G.
Institutes: Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University, Dept. of Urology, Guangzhou, China
865Comparison of Super-mini PCNL (SMP) versus Miniperc for stones larger than 2 cm: A propensity score-matching study
By: Zeng G. 1 , Liu Y. 2 , Zhu W. 3
Institutes: 1The First Affiliated Hospital of Guangzhou Medical University, Dept. of Urology, Guangzhou, China, 2The First Affiliated Hospital of Guangzhou Medical University, Minimally Invasive Surgery Center,Guangdong Key Laboratory of Urology, Dept. of Urology, Guangzhou, China, 3The First Affiliated Hospital of Guangzhou Medical University, Minimally Invasive Surgery Center,Guangdong Key Laboratory of Urology, Guangzhou, China
866867Are the different renal drainage options after percutaneous nephrolithotomy different in terms of efficacy and safety? Percutaneous nephrostomy and ureteral stents
By: Pimentel Torres J. , Oliveira J.N. , Mota P. , Cordeiro A. , Morais N. , Anacleto S. , Lima E.
Institutes: Hospital de Braga, Dept. of Urology, Braga, Portugal
-
Poster Session 33 - Better understanding LUTS: A look behind the curtain
Better understanding LUTS: A look behind the curtain Poster Session 33
Better understanding LUTS: A look behind the curtain
Poster Session 33
439Detrusor underactivity (DU) caused by bladder outlet obstruction (BOO) is associated with an early impairment of the bladder sensory mechanism
By: Vale L. 1 , Antunes-Lopes T. 1 , Avelino A. 1 , Birder L.A. 2 , Charrua A. 1 , Cruz F. 1
Institutes: 1Hospital Sao João & Faculty of Medicine/i3S of Porto, Dept. of Urology, Porto, Portugal, 2University of Pittsburgh, Dept. of Pharmacology, Pittsburgh, United States of America
440Overexpression of transient receptor potential vanilloid-4 (TRPV4) in urothelium of rat urinary bladder following bladder outlet obstruction
By: Cho Y.H. , Yu S.H. , Jeong S.H. , Park T.J. , Kim M.S. , Chung H.S. , Oh K.J. , Kim S-O. , Hwang E.C. , Jung S.I. , Kang T.W. , Park K. , Kwon D.D.
Institutes: Chonnam National University Hospital, Dept. of Urology, Gwangju, Korea, South
441MicroRNAs, inhibited by TNF-α, might influence smooth muscle remodeling during outlet obstruction-induced lower urinary tract dysfunction
By: Hashemi Gheinani A. 1 , Koeck I. 1 , Burkhard F. 2 , Monastyrskaya K. 1
Institutes: 1University of Bern, Dept. of BioMedical Research, Bern, Switzerland, 2University Hospital, Dept. of Urology, Bern, Switzerland
442Enhanced urinary extracellular vesicle isolation strategies to increase the yield and purity of human urinary exosomes for biomarker discovery
By: Hashemi Gheinani A. 1 , Vögeli M. 1 , Baumgartner U. 2 , Vassella E. 3 , Draeger A. 4 , Burkhard F. 5 , Monastyrskaya K. 1
Institutes: 1University of Bern, Dept. of BioMedical Research, Bern, Switzerland, 2University of Bern, Dept. of Urology, Bern, Switzerland, 3University of Bern, Dept. of Pathology, Bern, Switzerland, 4University of Bern, Dept. of Anatomy, Bern, Switzerland, 5University Hospital , Dept. of Urology, Bern, Switzerland
443444RQ-00434739, a novel TRPM8 antagonist, inhibits prostaglandin-E2-induced hyperactivity of the primary bladder afferent nerves in rats
By: Aizawa N. 1 , Ohshiro H. 2 , Watanabe S. 2 , Homma Y. 3 , Igawa Y. 1
Institutes: 1The University of Tokyo Graduate School of Medicine, Dept. of Continence Medicine, Tokyo, Japan, 2RaQualia Pharma Inc., Discovery Research, Nagoya, Japan, 3Japanese Red Cross Medical Center, Director, Tokyo, Japan
445Supraspinal lower urinary tract control in spinal cord injury patients undergoing intradetrusor onabotulinumtoxinA injections: An MRI study
By: Leitner L. 1 , Walter M. 1 , Liechti M. 1 , Michels L. 2 , Kollias S. 2 , Mehnert U. 1 , Kessler T. 1
Institutes: 1Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital, Dept. of Neuro-Urology, Zürich, Switzerland, 2University of Zürich, University Hospital Zürich, Institute of Neuro-Radiology, Zürich, Switzerland
446A three-dimensional scaffold containing encapsulated adipose-derived stem cells promotes bladder reconstruction via SDF-1α/CXCR4 pathway
By: Xiao D. 1 , Yan H. 1 , Zhang M. 1 , Lv X. 1 , Li W. 2 , Lu M. 1
Institutes: 1Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Dept. of Urology and Andrology, Shanghai, China, 2RenjiHospital Shanghai Jiao Tong University School Of Medicine, The State Key Lab of Metal Matrix Composites, Shanghai, China
447448fMRI in patients with detrusor sphincter dyssynergia - is the neural circuit affected?
By: Seseke S. 1 , Dechent P. 2 , Trojan L. 3
Institutes: 1Martha-Maria-Hospital Halle-Dölau, Dept. of Urology, Halle, Germany, 2Georg-August-University, Dept. of Cognitive Neurology, Göttingen, Germany, 3Georg-August-University, Dept. of Urology, Göttingen, Germany
449Inhibition of prostate smooth muscle contraction by inhibitors of polo-like kinases (PLK): A new role for PLK1 in smooth muscle contraction?
By: Hennenberg M. , Kuppermann P. , Yu Q. , Rutz B. , Wang Y. , Herlemann A. , Strittmatter F. , Stief C. , Gratzke C.
Institutes: University of Munich, Dept. of Urology, Munich, Germany
450451Withdrawn
452Epigenetic regulation of COX-2 expression by DNA methylation via NF-κB activation in ketamine-induced ulcerative cystitis
By: Juan Y-S. 1 , Chuang S-M. 2 , Wen-Jeng W. 1 , Chen-Yu L. 3 , Yi-Lun L. 4 , Chuang S-M. 2 , Weng-Chen W. 1
Institutes: 1Kaohsiung Municipal Ta-Tung Hospital, Dept. of Urology, Kaohsiung, Taiwan, 2Kaohsiung Medical University, Dept. of Urology, Kaohsiung, Taiwan, 3Kaohsiung Medical University, Dept. of Gynecology, Kaohsiung, Taiwan, 4Sinying Hospital, Dept. of Urology, Tainan, Taiwan
453A mussel protein-based underwater tissue adhesive sealant: Pre-clinical animal study for vesico-vaginal fistula
By: Pyun J.H. 1 , Kim H.J. 2 , Shim J.S. 3 , Kang S.G. 3 , Joo K.J. 1 , Cheon J. 3 , Cha H.J. 2 , Kang S.H. 3
Institutes: 1Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Dept. of Urology, Seoul, Korea, South, 2Pohang University of Science and Technology (POSTECH), Chemical Engineering, Seoul, Korea, South, 3Korea University College of Medicine, Dept. of Urology, Seoul, Korea, South
-
Specialty Session - Common problems in bladder cancer; evidence based debates
Common problems in bladder cancer; evidence based debates Specialty Session
Common problems in bladder cancer; evidence based debates
Specialty Session
-
Location:Green Area, Room 1 (Level 0)
-
Chairs:
-
Aims and objectives of this session After completion of this activity, participants will be able to:
• Discuss complex clinical changes in treating patients with bladder cancer.
• Discuss treatment alternatives in different bladder cancer disease states.
• Discuss the rationale for selecting particular therapy when a variety of treatment options exist.
• Discuss the clinical implications of biomarkers for diagnosis and prognosis.
Case-based Debate: Does variant histology change management of non-invasive bladder cancer? Questions and answers
Case-based Debate: My patient has a normal cystoscopy but a positive urine marker: What now? Questions and answers
Case-based Debate: Recurrent TaLG bladder tumours, failed BCG, Mitomycin: What are the options? Questions and answers
Case-based Debate: How should I treat a patient with initial T1HG disease and no tumour on re-TUR? Question and answers
Case-based Debate: What to do now that my patient’s tumour has been molecularly classified (and does it matter!)? Questions and answers
Case-based Debate: How should I manage a patient with tumour recurrence despite adequate BCG? Questions and answers
Case-based Debate: How to treat multi-focal Ta, HG disease if BCG is unavailable? Questions and answers
Case-based Debate: Marker-driven use of NAC in (T2) urothelial cancer in an otherwise healthy patient? -
-
Poster Session 73 - Safe access through natural orifice: It is the era of ureteroscopy
Safe access through natural orifice: It is the era of ureteroscopy Poster Session 73
Safe access through natural orifice: It is the era of ureteroscopy
Poster Session 73
Double-blinded prospective randomized clinical trial comparing regular and moses modes of holmium laser lithotripsy: Preliminary results
By: Ibrahim A. , Fahmy N. , Carrier S. , Elhilali M. , Andonian S.
Institutes: McGill University Health Centre, Dept. of Urology, Montreal, Canada
991The comparative clinical study of Ho: YAG and SuperPulse Tm fiber laser lithotripters
By: Ergakov D. 1 , Martov A.G. 1 , Guseynov M. 1 , Traxer O. 2
Institutes: 1Moscow City D.D. Pletnew's Hospital, Dept. of Urology, Moscow, Russia, 2Université Pierre et Marie Curie, Paris, France
V06Understanding non-contact laser lithotripsy for dusting – the popcorn effect: A video analysis To be confirmed
992993Spinal versus general anesthesia for retrograde intrarenal surgery: A prospective double-blinded randomized-controlled trial
By: Mohamed M.H.A.T. 1 , Al-Hamri S. 2 , Askar A. 2 , Al-Rawagadh M. 3
Institutes: 1Cairo University, Dept. of Urology, Cairo, Egypt, 2National Guard Hospital, Dept. of Urology, Riyadh, Saudi Arabia, 3AL-Moosa Specialized Hospital, Dept. of Urology, Alahsa, Saudi Arabia
994Comparison of eight digital (reusable and disposable) flexible ureteroscopes deflection properties: In-vitro study in 10 different scope settings
By: Dragos L.B. 1 , Rodriguez-Monsalve Herrero M. 2 , Somani B.K. 3 , Keller E.X. 2 , De Coninck V. 2 , Martis S.M. 4 , Bres-Niewada E. 5 , Sener T.E. 6 , Buttice S. 7 , Daminescu L.C. 4 , Pupca G.N. 1 , Bardan R.T. 1 , Cumpanas A.A. 1 , Iacoboaie C. 2 , Doizi S. 2 , Traxer O. 8
Institutes: 1University of Medicine and Pharmacy, Dept. of Urology, Timisoara, Romania, 2Tenon Hospital, Dept. of Urology, Paris, France, 3University Hospital Southampton NHS Trust, Dept. of Urology, Southampton, United Kingdom, 4Emergency Clinical County Hospital, Dept. of Urology, Timisoara, Romania, 5Medical University of Warsaw, Dept. of Urology, Warsaw, Poland, 6Marmara University, Dept. of Urology, Istanbul, Turkey, 7San Giovanni di Dio Hospital, Dept. of Urology, Agrigento, Italy, 8Tenon Hospital, Sorbonne Universités, UPMC Paris VI, Groupe de Recherche Clinique sur la Lithiase Urinaire, GRC nº20, Dept. of Urology, Paris, France
995Single-use versus reusable ureteroscopes for retrograde intrarenal surgery (RIRS): Systematic comparative analysis of physical and optical properties in three different devices
By: Deininger S. , Haberstock L. , Todenhoefer T. , Neumann E. , Bedke J. , Stenzl A. , Kruck S. , Rausch S.
Institutes: Eberhard-Karls-University Tuebingen, Dept. of Urology, Tübingen, Germany
996997Comparison of intrarenal pelvic pressure levels during flexible ureteroscopy, mini-percutaneous nephrolithotomy and conventional percutaneous nephrolithotomy in a kidney model
By: Doizi S. , Uzan A. , Keller E. , De Coninck V. , Rodriguez-Monsalve Herrero M. , Traxer O.
Institutes: Tenon Hospital, Assistance-Publique Hôpitaux de Paris. Pierre et Marie Curie University., Dept. of Urology, Paris, France
998Comparison of stone free rates and quality of life between percutaneous nephrolithotomy (PNL) and retrograde intra-renal surgery (RIRS) in management of 2-4 cm renal stones: A prospective controlled study
By: Üçer O. , Erbatu O. , Albaz A.C. , Temeltaş G. , Gümüş B. , Müezzinoğlu T.
Institutes: Manisa Celal Bayar University, Faculty of Medicine, Dept. of Urology, Manisa, Turkey
999Head to head comparison of flexible ureterorenoscopy (fURS) versus robot-assisted flexible URS (rfURS) using the Avicenna Roboflex URS robot
By: Klein J-T. 1 , Charalampogianis N. 2 , Fiedler M. 2 , Kabakci S. 3 , Tokatli Z. 4 , Rassweiler J. 2
Institutes: 1University Hospital, Dept. of Urology and Pediatric Urology, Ulm, Germany, 2SLK-Kliniken GmbH, Dept. of Urology , Heilbronn, Germany, 3University Ankara, Dept. of Bioengineering, Ankara, Turkey, 4Medicana International Ankara, Dept. of Urology, Ankara, Turkey
1000Reducing operative complications from kidney stones (ROCKS): Understanding emergency department visits after ureteroscopy in a statewide collaborative
By: Ghani K. 1 , Kim T. 1 , Telang J. 1 , Johnson A. 1 , Roberts W. 1 , Tekchandani A. 2 , Wynberg J. 3 , Leese J. 4 , Kadlec A. 5 , Dauw C. 1 , Hollingsworth J.M. 1
Institutes: 1University of Michigan, Dept. of Urology, Ann Arbor, United States of America, 2MidMichigan Health, Dept. of Urology, Midland, United States of America, 3Detroit Medical Center, Dept. of Urology, Detroit, United States of America, 4IHA Urology, Dept. of Urology, Ann Arbor, United States of America, 5West Michigan Urological Associates, Dept. of Urology, Holland, United States of America
1001Ureterorenoscopy with double JJ stent and its impact on sexual function in young men: A prospective randomised multicenter controlled study
By: Khouni H. 1 , Boulma R. 1 , Raboudi M. 1 , Khiari R. 2 , Ghozzi S. 2 , Ben Rais N. 2
Institutes: 1Internal Forces security Hospital, Dept. of Urology, La Marsa, Tunisia, 2Military Hospital, Dept. of Urology, Tunis, Tunisia
-
Poster Session 43 - Whats new from the bench: Treating or preventing LUTS
Whats new from the bench: Treating or preventing LUTS Poster Session 43
Whats new from the bench: Treating or preventing LUTS
Poster Session 43
578Which mechanism account for chronic bladder pain that develops later in life in individuals who suffer stressful events during infancy and adolescence?
By: Matos R. 1 , Serrão P. 2 , Cruz F. 3 , Charrua A. 1
Institutes: 1Faculty of Medicine of University of Porto, Dept. of Biomedical Science, Porto, Portugal, 2University of Porto, Dept. of Biomedical Science, Porto, Portugal, 3University of Porto, Dept. of Urology, Porto, Portugal
579Anti-Nogo-A antibodies: A causal treatment for neurogenic lower urinary tract dysfunction due to spinal cord injury?
By: Schneider M.P. 1 , Sartori A. 1 , Ineichen B. 1 , Schwab M. 2 , Kessler T. 1
Institutes: 1University of Zürich, Balgrist University Hospital, Spinal Cord Injury Center & Research, Dept. of Neuro-Urology, Zürich, Switzerland, 2Brain Research Institute, University of Zürich, Dept. of Health Sciences and Technology, Zürich, Switzerland
580Prevention of neurogenic detrusor overactivity following spinal cord injury: Effects of early administration of resiniferatoxin and botulinum toxin A
By: Oliveira R. 1 , Sousa Chambel S. 1 , Silva R. 1 , Coelho A. 1 , Cruz F. 2 , Duarte Cruz C. 1
Institutes: 1Faculty of Medicine, University of Porto, Dept. of Biomedicine, Porto, Portugal, 2Hospital São João, Dept. of Urology, Porto, Portugal
581ESWT protects from bladder dysfunction after traumatic spinal cord injury via a toll-like receptor 3 dependent mechanism
By: Nägele F. 1 , An A. 1 , Graber M. 1 , Lobenwein D. 2 , Kremser C. 3 , Hirsch J. 1 , Pölzl L. 1 , Grimm M. 1 , Holfeld J. 1 , Tepeköylü C. 1
Institutes: 1Innsbruck Medical University, University Hospital for Cardiac Surgery, Innsbruck, Austria, 2Innsbruck Medical University, Dept. of Clinical and Functional Anatomy, Dept. of Anatomy, Histology and Embryology, Innsbruck, Austria, 3Innsbruck Medical University, Dept. of Radiology, Innsbruck, Austria
582Can antioxidant therapy be protective against diabetes-induced bladder dysfunction?
By: Tsounapi P. 1 , Honda M. 1 , Shimizu R. 1 , Nishikawa R. 1 , Teraoka S. 1 , Kimura Y. 1 , Yumioka T. 1 , Yamaguchi N. 1 , Iwamoto H. 1 , Morizane S. 1 , Dimitriadis F. 2 , Hikita K. 1 , Sofikitis N. 3 , Takenaka A. 1
Institutes: 1Tottori University Faculty of Medicine, Dept. of Urology, Yonago, Japan, 2Aristotle University of Thessaloniki School of Medicine, Dept. of Urology, Thessaloniki, Greece, 3University of Ioannina, School of Medicine, Dept. of Urology, Ioannina, Greece
583The finasteride can promote kidney changes? A study developed in a model of benign prostatic hyperplasia
By: Da Silva M. , Estrada J. , Sampaio F. , De Souza D.
Institutes: State University of Rio de Janeiro, Urogenital Research Unit, Rio de Janeiro, Brazil
584Protective effect of platelet-rich plasma on urethral injury model of male rats in bladder
By: Tavukçu H.H. 1 , Aytaç O. 1 , Atuğ F. 1 , Alev B. 2 , Çevik Ö. 3 , Yarat A. 4 , Ceti̇nel S. 5 , Sener G. 2 , Kulaksizoglu H.K. 1
Institutes: 1Istanbul Bilim University, Istanbul Florence Nightingale Hospital, Dept. of Urology, Istanbul, Turkey, 2Marmara University, School of Pharmacy, Dept. of Pharmacology, Istanbul, Turkey, 3Adnan Menderes University, School of Medicine, Dept. of Biochemistry, Aydin, Turkey, 4Marmara University, Faculty of Dentistry, Dept. of Biochemistry, Istanbul, Turkey, 5Marmara University, School of Medicine, Dept. of Histology & Embryology, Istanbul, Turkey
585Maternal high-fat diet promoted prostatic atrophy in Wistar rats’ offspring
By: Campos-Silva P. , Souza-Fernandes A. , De Souza D. , Gallo C. , Costa W. , Sampaio F. , Gregorio B.M.
Institutes: State University of Rio de Janeiro, Dept. of Anatomy, Rio de Janeiro, Brazil
586Early fesoterodine fumarate administration prevents the onset of neurogenic detrusor overactivity after spinalization in rats: Mechanism of action
By: Przydacz M. 1 , Loutochin G. 1 , Biardeau X. 1 , Cammisotto P. 1 , Zimoch J. 2 , Benlimame N. 3 , Campeau L. 1 , Corcos J. 1
Institutes: 1Jewish General Hospital, Dept. of Urology, Montreal, Canada, 2University Children's Hospital, Dept. of Surgery, Zurich, Switzerland, 3Jewish General Hospital, Dept. of Cancer, Montreal, Canada
587Does electrical stimulation in the lower urinary tract induce diuresis?
By: Van Der Lely S. 1 , Liechti M. 1 , Popp W. 2 , Kessler T. 1 , Mehnert U. 1
Institutes: 1Balgrist University Hospital, Spinal Cord Injury Center, Dept. of Neuro-Urology, Zurich, Switzerland, 2ETH Zurich, Rehabilitation Engineering Laboratory, Zurich, Switzerland
588Effects of castration and testosterone replacement over serotonin (prostatic and plasmatic): An in vivo study
By: Oliveira Da Mota P. 1 , Lopes Cordeiro A. 1 , Martins J. 1 , Torres J. 1 , Morais N. 1 , Moura R. 2 , Miranda A. 2 , Correia-Pinto J. 1 , Lima E. 1 , Carvalho-Dias E. 1
Institutes: 1Hospital de Braga, Surgical Sciences Research Domain, Life and Health Sciences Research Institute, ICVS/3B’s - PT Gover, Dept. of CUF Urology and Service of Urology, Braga, Portugal, 2University of Minho, Hospital de Braga, Surgical Sciences Research Domain, Life and Health Sciences Research Institute, ICVS/3B’s - PT Gover, Dept. of CUF Urology and Service of Urology, Braga, Portugal
589Carbon and zeolite impregnated polyester fabric inhibits urine odour: A randomized experimental study
By: Taverna G. 1 , Grizzi F. 2 , Thiel L. 3 , Stork B. 4 , Justich M. 1 , Melegari S. 1 , Seveso M. 1 , Bozzini G. 1 , De Francesco O. 1 , Miller D. 5 , Tidu L. 6 , Hurle R. 7 , Lughezzani G. 7 , Casale P. 7 , Pasini L. 7 , Benetti A. 7 , Mandressi A. 1 , Guazzoni G.F. 7
Institutes: 1Humanitas Mater Domini, Dept. of Urology, Castellanza, Italy, 2Humanitas Clinical and Research Center, Dept. of Immunology and Inflammation, Rozzano, Italy, 3College of Health Professions, University of Detroit Mercy, McAuley School of Nursing, Detroit, United States of America, 4University of Michigan, School of Medicine, Dept. of Urology, Ann Arbor, United States of America, 5Mercy Health VNS, Nurses Services and Hospice Services, Muskegon, United States of America, 6Italian Ministry of Defences, Military Veterinary Center, Grosseto, Italy, 7Humanitas Clinical and Research Center, Dept. of Urology, Rozzano, Italy
590Rno-miR-199a-3p antagonism prevents glomerulosclerosis in the Fischer-344 to Lewis rat model of antibody-mediated rejection
By: Zeuschner P. 1 , Grau V. 2 , Padberg W. 3 , Becker J.U. 4 , Dieplinger G. 5
Institutes: 1Saarland University Medical Center, Dept. of Urology and Pediatric Urology, Homburg, Germany, 2Justus-Liebig-University Giessen, Laboratory of Experimental Surgery, Dept. of General and Thoracic Surgery, Giessen, Germany, 3Justus-Liebig-University Giessen, Dept. of General and Thoracic Surgery, Giessen, Germany, 4University Hospital of Cologne, Dept. of Pathology, Cologne, Germany, 5Transplant Center Cologne, Dept. of General, Visceral and Cancer Surgery, Cologne, Germany
591Comparison between nanotechnology structured water (magnalife) and tadalafil for the treatment of erectile dysfunction
By: Sami A.K. 1 , Alshimmre R. 2 , Moudhaffer Alkhalidi I. 3 , Jasim Alzaidy O. 4
Institutes: 1University of Sulaimani, Dept. of Urology, Sulaimani, Iraq, 2Ghazi Alhariri Hospital, Dept. of Urology, Baghdad, Iraq, 3University of Baghdad, Dept. of Urology, Baghdad, Iraq, 4Baaquba teaching hospital, Dept. of Urology, Baaquba, Iraq
592In vivo neo bladder regeneration by the presence of human adipose tissue derived mesenchymal stem cells
By: Morera Esteve M.J. 1 , Mellado-Lopez M. 2 , Forteza J. 3 , Moreno-Manzano V. 2 , Vera Donoso C.D. 4
Institutes: 1Centro de Investigación Príncipe Felipe, Neuronal and Tissue Regeneration Laboratory, Valencia, Spain, 2Centro de Investigación Príncipe Felipe (CIPF), Neuronal and Tissue Regeneration Laboratory, Valencia, Spain, 3Joint Unit of Molecular Pathology CIPF-UCV, Valencia, Spain, 4Hospital la Fe, Dept. of Urology, Valencia, Spain
-
Poster Session 83 - New insights in LUTS/BPH pathophysiology and therapeutic targets
New insights in LUTS/BPH pathophysiology and therapeutic targets Poster Session 83
New insights in LUTS/BPH pathophysiology and therapeutic targets
Poster Session 83
-
Location:Green Area, Room 1 (Level 0)
-
Chairs:
- Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are 3 minutes in length, followed by 3 minutes for discussion.
1124* 1125Allopurinol and risk of benign prostatic hyperplasia in a Finnish population-based cohort
By: Kukko V. 1 , Kaipia A. 2 , Talala K. 3 , Taari K. 4 , Tammela T.L.J 1 , Auvinen A. 5 , Murtola T. 1
Institutes: 1University of Tampere, Faculty of Medicine and Life Sciences, Tampere, Finland, 2Tampere University hospital, Dept. of Urology, Tampere, Finland, 3Finnish Cancer Registry, Dept. of Statistics, Helsinki, Finland, 4University of Helsinki and Helsinki University Hospital, Dept. of Urology, Helsinki, Finland, 5University of Tampere, Faculty of Social Sciences, Tampere, Finland
1126Statins use is associated with reduce the risk of clinical benign prostatic hyperplasia in patients with hyperlipidemia
By: Shih H.J. 1 , Huang C-J. 2 , Tsai P-S. 3 , Fan Y-C. 2
Institutes: 1Wan Fang Hospital, Taipei Medical University, Dept. of Urology, Taipei, Taiwan, 2Wan Fang Hospital, Taipei Medical University, Dept. of Anesthesiology, Taipei, Taiwan, 3College of Nursing, Taipei Medical University, Graduate Institute of Nursing, Taipei, Taiwan
1127Sexual steroids in serum and prostatic tissue of human non-cancerous prostate (STERPROSER Trial)
By: Neuzillet Y. 1 , Raynaud J.P. 2 , Radulescu C. 3 , Fiet J. 4 , Giton F. 4 , Dreyfus J.F. 5 , Ghoneim T. 1 , Rouanne M. 1 , Lebret T. 1 , Botto H. 1
Institutes: 1Hôpital Foch, University of Versailles - Saint-Quentin-en-Yvelines, Dept. of Urology, Suresnes, France, 2University Pierre et Marie Curie, Dept. of Research, Paris, France, 3Hôpital Foch, University of Versailles - Saint-Quentin-en-Yvelines, Dept. of Pathology, Suresnes, France, 4Inserm U955, EQ07, Center of Chirurgical Research, Créteil, France, 5Hôpital Foch, University of Versailles - Saint-Quentin-en-Yvelines, Dept. of Research, Suresnes, France
1128Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia
By: Inamura S. 1 , Ito H. 1 , Shinagawa T. 1 , Tsutsumiuchi M. 1 , Taga M. 1 , Kobayashi M. 2 , Yokoyama O. 1
Institutes: 1University of Fukui, Dept. of Urology, Eiheiji. Fukui, Japan, 2University of Fukui, Dept. of Tumor Pathology, Eiheiji. Fukui, Japan
1129Antidiabetic drugs and risk of benign prostatic hyperplasia
By: Nygård L. 1 , Talala K. 2 , Taari K. 3 , Tammela T. 4 , Auvinen A. 5 , Murtola T.J. 4
Institutes: 1University of Tampere, Faculty of Medicine and Life Sciences, Tampere, Finland, 2Cancer Society of Finland, Finnish Cancer Registry, Helsinki, Finland, 3University of Helsinki and Helsinki University Hospital, Dept. of Urology, Helsinki, Finland, 4Tampere University Hospital, Dept. of Urology, Tampere, Finland, 5University of Tampere, Faculty of Social Sciences, Tampere, Finland
11301131Phosphodiesterase 4b expression in a canine experimental model of benign prostatic hyperplasia
By: Gasa Galmes B.I. 1 , García-Larrosa A. 1 , Sanchez Guerri I. 2 , Juanpere Rodero N. 2 , Mogas Amorós T. 3 , Lloreta Trull J. 2 , Cecchini Rosell L. 1
Institutes: 1Hospital del Mar, Dept. of Urology, Barcelona, Spain, 2Hospital del Mar, Dept. of Pathology, Barcelona, Spain, 3Autonomous University of Barcelona, Dept. of Animal Medicine and Surgery of Veterinary Faculty, Bellaterra, Spain
* 1132Novel evidence for a role of the ghrelin system in the hyperplastic prostate: Connecting the metabolic syndrome and lower urinary tract symptoms suggestive of BPH?
By: Wang X. , Gratzke C. , Wang Y. , Sterr C. , Yu Q. , Strittmatter F. , Stief C. , Hennenberg M.
Institutes: University of Munich, Dept. of Urology, Munich, Germany
-
-